Articles les plus consultés

mercredi 4 avril 2018

Les dirigeants d'Ex-Kite forment un rival de la CAR T | Pharmafile

Les dirigeants d'Ex-Kite forment un rival de la CAR T | Pharmafile

Les dirigeants d'Ex-Kite forment un rival de la CAR T | Pharmafile

Les dirigeants d'Ex-Kite forment un rival de la CAR T | Pharmafile

Audi to double sales - Global Times

Audi to double sales - Global Times

Poxel Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference | Business Wire

Poxel Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference | Business Wire: POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic diseases, in

ThromboGenics Reports Initial Data from its Clinical Study evaluating THR-317, an anti-PlGF, for the Treatment of Diabetic Macular Edema (DME)

ThromboGenics Reports Initial Data from its Clinical Study evaluating THR-317, an anti-PlGF, for the Treatment of Diabetic Macular Edema (DME)

RefleXion Medical Raises $100 Million Series C to Commercialize Revolutionary Cancer Treatment

RefleXion Medical Raises $100 Million Series C to Commercialize Revolutionary Cancer Treatment: World’s Only Biology-Guided Radiation Therapy Could Help Millions More Patients Worldwide

GM Korea March sales slump - Global Times

GM Korea March sales slump - Global Times